Company: THC
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0000070318-25-000046
Chunk: 98

Company: TENET HEALTHCARE CORP
Filing Date: 2025-10-28
Form: 10-Q
Item: Part I, Item 1
Chunk 98
---
 totaling $20 million and $4 million during the three and nine months ended September 30, 2025, respectively. During the three months ended September 30, 2025, we recorded gains of $21 million related to the consolidation of certain facilities by our Ambulatory Care Segment and net losses of $1 million related to other activity. During the nine-month period, we recorded net losses of $12 million related to the consolidation of certain facilities by our Ambulatory Care segment, partially offset by a gain of $10 million related to post‑closing adjustments from the divestiture of the AL Hospitals, net gains of $4 million from the sale of facilities by our Ambulatory Care segment and net gains of $2 million related to other activity.

We recorded gains from the sale, consolidation and deconsolidation of facilities totaling $348 million and $2.906 billion during the three and nine months ended September 30, 2024, respectively. Gains recognized during the three‑month period primarily consisted of a gain of $357 million recognized from our divestiture of the AL Hospitals. During the nine months ended September 30, 2024, we also recognized a gain of $1.677 billion related to our sale of the SC Hospitals, 

40

a gain of $527 million from the sale of the OCLA CA Hospitals, a gain of $271 million from our sale of the Central CA Hospitals and a gain of $43 million from the sale of three ASCs by our Ambulatory Care segment.

Interest Expense

Interest expense for the three and nine months ended September 30, 2025 was $206 million and $616 million, respectively, compared to $202 million and $623 million, respectively, for the same periods in 2024.

Loss from Early Extinguishment of Debt

We did not incur any losses related to the early extinguishment of debt during the nine months ended September 30, 2025. During the nine months ended September 30, 2024, we recorded losses of $8 million related to our redemption of our 4.875% senior secured first lien notes due 2026 in advance of their maturity date. This loss derived from the write‑off of unamortized issuance costs associated with these notes.

Income Tax Expense

A reconciliation between the amount of reported income tax expense and the amount computed by